UroGen Pharma Ltd.
URGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001668243
In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in UroGen Pharma Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +7 vs. Q4 2023
- Shares held
- 27.2M
- +5.76M (+26.9%) vs. Q4 2023
- Total value
- $407.4M
- +$86.2M (+26.8%) vs. Q4 2023
- New holders
- 20
- 31 more added
- Sold out
- 13
- 36 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 190 | $1.56B |
| Q1 2026 | 173 | $835.2M |
| Q4 2025 | 167 | $1.02B |
| Q3 2025 | 161 | $878.6M |
| Q2 2025 | 150 | $545.2M |
| Q1 2025 | 140 | $460.6M |
| Q4 2024 | 138 | $386.3M |
| Q3 2024 | 128 | $445.7M |
| Q2 2024 | 115 | $641.4M |
| Q1 2024 | 112 | $407.4M |
| Q4 2023 | 105 | $321.2M |
| Q3 2023 | 101 | $248.3M |
| Q2 2023 | 85 | $137.8M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 64 | $115.4M |
| Q3 2022 | 60 | $110.8M |
| Q2 2022 | 65 | $109.2M |
| Q1 2022 | 84 | $123.9M |
| Q4 2021 | 78 | $140.4M |
| Q3 2021 | 93 | $236.9M |
| Q2 2021 | 82 | $213.7M |
| Q1 2021 | 89 | $278.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 673,487 | $10.1M | 0.20% | −196,558−22.6% | Reduced |
| Migdal Insurance & Financial Holdings Ltd. | 686,472 | $10.3M | 0.16% | +38,170+5.9% | Added |
| Jefferies Financial Group Inc. | 840,000 | $12.6M | 0.25% | +840,000 | New |
| Point72 Asset Management, L.P. | 1,112,020 | $16.7M | 0.05% | +986,020+782.6% | Added |
| Credit Suisse AG | 1,200,000 | $18.0M | 0.02% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,300,000 | $19.5M | 0.04% | +1,300,000 | New |
| Cowen and Company, LLC | 1,626,589 | $24.4M | 0.95% | +1,626,589 | New |
| BlackRock Inc. | 1,716,813 | $25.8M | 0.00% | −2,491−0.1% | Reduced |
| Menora Mivtachim Holdings Ltd. | 2,303,031 | $34.5M | 0.26% | 00.0% | Unchanged |
| Great Point Partners LLC | 2,620,545 | $39.3M | 6.13% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,083,430 | $46.3M | 0.59% | 00.0% | Unchanged |
| RTW Investments, LP | 3,257,347 | $48.9M | 0.72% | +1,530,539+88.6% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −91,300−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −77,873−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −28,552−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −27,218−100.0% | Sold out |
| Partners Capital Investment Group, LLP | 0 | $0 | 0.00% | −15,384−100.0% | Sold out |
| Sierra Summit Advisors LLC | 0 | $0 | 0.00% | −14,515−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −11,709−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −11,348−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,080−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −8,707−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −354−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |